Ozempic: Ozempic , while primarily approved for managing type 2 diabetes, is often prescribed off-label for weight loss
While genetics don't guarantee results, they reveal your biological predisposition to respond well to GLP-1 therapy, helping your provider optimize your treatment approach for maximum effectiveness
10.1016/j.jad.2019.05.044 59 ReadJ
Research Highlights: In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor medication had a lower risk of a subsequent stroke, heart attack or death compared to peers who were not prescribed the medications during a three-year follow up period
This year especially, we see many patients asking specially for weight loss medications
Retatrutide faces market forces against proven alternatives, some already with positive coverage and wider adoption